Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.20 USD
-0.07 (-5.51%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.21 +0.01 (0.83%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: AMC |
6/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Nektar Therapeutics (NKTR) reported earnings of -$0.18 per share, beating the Zacks Consensus Estimate of $-0.21 per share. This reflects a positive earnings surprise of 14.29%. Look out for NKTR's next earnings release on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 22.22%.
Earnings History
Price & Consensus
Zacks News for NKTR
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
NKTR: What are Zacks experts saying now?
Zacks Private Portfolio Services